314 related articles for article (PubMed ID: 30825964)
21. Treatment plan quality during online adaptive re-planning.
van Timmeren JE; Chamberlain M; Krayenbuehl J; Wilke L; Ehrbar S; Bogowicz M; Hartley C; Zamburlini M; Andratschke N; Garcia Schüler H; Pavic M; Balermpas P; Ryu C; Guckenberger M; Tanadini-Lang S
Radiat Oncol; 2020 Aug; 15(1):203. PubMed ID: 32825848
[TBL] [Abstract][Full Text] [Related]
22. Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate.
Nierer L; Eze C; da Silva Mendes V; Braun J; Thum P; von Bestenbostel R; Kurz C; Landry G; Reiner M; Niyazi M; Belka C; Corradini S
Radiat Oncol; 2022 Mar; 17(1):53. PubMed ID: 35279185
[TBL] [Abstract][Full Text] [Related]
23. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
[TBL] [Abstract][Full Text] [Related]
24. Intrafraction organ movement in adaptive MR-guided radiotherapy of abdominal lesions - dosimetric impact and how to detect its extent in advance.
Buchele C; Renkamp CK; Regnery S; Behnisch R; Rippke C; Schlüter F; Hoegen-Saßmannshausen P; Debus J; Hörner-Rieber J; Alber M; Klüter S
Radiat Oncol; 2024 Jun; 19(1):80. PubMed ID: 38918828
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk.
Loi M; Magallon-Baro A; Suker M; van Eijck C; Sharma A; Hoogeman M; Nuyttens J
Radiother Oncol; 2019 May; 134():67-73. PubMed ID: 31005226
[TBL] [Abstract][Full Text] [Related]
26. Predicting personalised and progressive adaptive dose escalation to gross tumour volume using knowledge-based planning models for inoperable advanced-stage non-small cell lung cancer patients treated with volumetric modulated arc therapy.
Tambe NS; Pires IM; Moore C; Wieczorek A; Upadhyay S; Beavis AW
Biomed Phys Eng Express; 2022 Mar; 8(3):. PubMed ID: 35189613
[No Abstract] [Full Text] [Related]
27. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
Qin A; Sun Y; Liang J; Yan D
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
[TBL] [Abstract][Full Text] [Related]
28. On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations.
Placidi L; Romano A; Chiloiro G; Cusumano D; Boldrini L; Cellini F; Mattiucci GC; Valentini V
Tech Innov Patient Support Radiat Oncol; 2020 Sep; 15():15-21. PubMed ID: 32642565
[TBL] [Abstract][Full Text] [Related]
29. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
[TBL] [Abstract][Full Text] [Related]
30. In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiation Therapy (CT-STAR) for the Treatment of Abdominal Oligometastases.
Schiff JP; Stowe HB; Price A; Laugeman E; Hatscher C; Hugo GD; Badiyan SN; Kim H; Robinson CG; Henke LE
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):1022-1031. PubMed ID: 35768023
[TBL] [Abstract][Full Text] [Related]
31. Characterization and management of interfractional anatomic changes for pancreatic cancer radiotherapy.
Liu F; Erickson B; Peng C; Li XA
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e423-9. PubMed ID: 22436785
[TBL] [Abstract][Full Text] [Related]
32. CT-guided versus MR-guided radiotherapy: Impact on gastrointestinal sparing in adrenal stereotactic body radiotherapy.
Rodriguez LL; Kotecha R; Tom MC; Chuong MD; Contreras JA; Romaguera T; Alvarez D; McCulloch J; Herrera R; Hernandez RJ; Mercado J; Mehta MP; Gutierrez AN; Mittauer KE
Radiother Oncol; 2022 Jan; 166():101-109. PubMed ID: 34843842
[TBL] [Abstract][Full Text] [Related]
33. Comparison of various online strategies to account for interfractional variations for pancreatic cancer.
Ahunbay EE; Kimura B; Liu F; Erickson BA; Li XA
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):914-21. PubMed ID: 23845843
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic MR-guided online adaptive radiotherapy reirradiation (SMART reRT) for locally recurrent pancreatic adenocarcinoma: A case report.
Doty DG; Chuong MD; Gomez AG; Bryant J; Contreras J; Romaguera T; Alvarez D; Kotecha R; Mehta MP; Gutierrez AN; Mittauer KE
Med Dosim; 2021 Winter; 46(4):384-388. PubMed ID: 34120803
[TBL] [Abstract][Full Text] [Related]
35. Head and Neck Margin Reduction With Adaptive Radiation Therapy: Robustness of Treatment Plans Against Anatomy Changes.
van Kranen S; Hamming-Vrieze O; Wolf A; Damen E; van Herk M; Sonke JJ
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):653-60. PubMed ID: 27681762
[TBL] [Abstract][Full Text] [Related]
36. Dosimetric analysis of stereotactic rotational versus static intensity-modulated radiation therapy for pancreatic cancer.
Cho I; Park JW; Cho B; Kwak J; Yoon SM; Nesseler JP; Park J; Kim JH
Cancer Radiother; 2018 Dec; 22(8):754-762. PubMed ID: 30322818
[TBL] [Abstract][Full Text] [Related]
37. Impact of intrafraction motion in pancreatic cancer treatments with MR-guided adaptive radiation therapy.
Rusu DN; Cunningham JM; Arch JV; Chetty IJ; Parikh PJ; Dolan JL
Front Oncol; 2023; 13():1298099. PubMed ID: 38162503
[TBL] [Abstract][Full Text] [Related]
38. Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer.
Hawranko R; Sohn JJ; Neiderer K; Bump E; Harris T; Fields EC; Weiss E; Song WY
J Clin Med; 2022 May; 11(9):. PubMed ID: 35566712
[TBL] [Abstract][Full Text] [Related]
39. Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
McDonald BA; Vedam S; Yang J; Wang J; Castillo P; Lee B; Sobremonte A; Ahmed S; Ding Y; Mohamed ASR; Balter P; Hughes N; Thorwarth D; Nachbar M; Philippens MEP; Terhaard CHJ; Zips D; Böke S; Awan MJ; Christodouleas J; Fuller CD;
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1606-1618. PubMed ID: 33340604
[TBL] [Abstract][Full Text] [Related]
40. MRI-based high-precision irradiation in an orthotopic pancreatic tumor mouse model : A treatment planning study.
Dobiasch S; Kampfer S; Habermehl D; Duma MN; Felix K; Strauss A; Schilling D; Wilkens JJ; Combs SE
Strahlenther Onkol; 2018 Oct; 194(10):944-952. PubMed ID: 29947818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
